In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000918:Antibody Specificity; D003630:Daunorubicin / Q000378:metabolism / Q000627:therapeutic use*; D004317:Doxorubicin / Q000378:metabolism / Q000627:therapeutic use*; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D007140:Immunoglobulin Fab Fragments / Q000276:immunology; D008113:Liver Neoplasms / Q000188:drug therapy; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D046911:Macromolecular Substances; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats
D000912:Antibodies, Neoplasm; D004338:Drug Combinations; D007140:Immunoglobulin Fab Fragments; D046911:Macromolecular Substances; D004317:Doxorubicin; D003630:Daunorubicin